Inhibikase Therapeutics, Inc. (IKT) SEC filings
IKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$1.38−0.07 (-4.83%)
Close on Nov 17, 2026Market cap $192.56MP/E –Yield –
SEC filings
40 of Inhibikase Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 10, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2026 | Nov 10, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 19, 2026 | Oct 20, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 8, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 21, 2026 | Aug 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 23, 2026 | Jul 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2026 | Jul 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2026 | Jun 29, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 26, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2026 | Apr 7, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2025 | Dec 19, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2025 | Nov 21, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2025 | Nov 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2025 | Jun 30, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 27, 2025 | May 12, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 11, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2025 | Mar 27, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 21, 2025 | Feb 24, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 13, 2025 | Feb 18, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 29, 2025 | Jan 29, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 3, 2025 | Jan 6, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2024 | Dec 5, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 3, 2025 | Nov 18, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 21, 2024 | Oct 22, 2024 | SEC EDGAR |
See a number that looks wrong?